118 related articles for article (PubMed ID: 3577680)
41. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
[TBL] [Abstract][Full Text] [Related]
42. Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis.
Thompson EJ; Riches PG; Kohn J
J Clin Pathol; 1983 Mar; 36(3):312-5. PubMed ID: 6826780
[TBL] [Abstract][Full Text] [Related]
43. Schemes to eradicate the multiple sclerosis central nervous system immune reaction.
Tourtellotte WW; Murthy K; Brandes D; Sajben N; Ma B; Comiso P; Potvin A; Costanza A; Korelitz J
Neurology; 1976 Jun; 26(6 PT 2):59-61. PubMed ID: 179031
[No Abstract] [Full Text] [Related]
44. Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.
Rocchelli B; Poloni M; Mazzarello P; Piccolo G; Delodovici M; Pinelli P
Ital J Neurol Sci; 1982 Jul; 3(2):119-26. PubMed ID: 6896866
[No Abstract] [Full Text] [Related]
45. The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings.
Trojano M; Logroscino GC; Pisicchio L; Rosato A; Bordo B; Citterio A; Amato MP; Livrea P
Ital J Neurol Sci; 1987 Jun; Suppl 6():71-6. PubMed ID: 3654180
[TBL] [Abstract][Full Text] [Related]
46. Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters.
Anderson TJ; Donaldson IM; Sheat JM; George PM
Aust N Z J Med; 1990 Dec; 20(6):794-7. PubMed ID: 2291728
[TBL] [Abstract][Full Text] [Related]
47. Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source.
Zeman AZ; Keir G; Luxton R; Thompson EJ
QJM; 1996 Mar; 89(3):187-93. PubMed ID: 8731562
[TBL] [Abstract][Full Text] [Related]
48. IgG synthesis rate in evaluation of multiple sclerosis in a community hospital.
Matteson EL; Flagler DG; Mesara BW
Neurology; 1987 May; 37(5):847-9. PubMed ID: 3574688
[TBL] [Abstract][Full Text] [Related]
49. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis].
Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E
Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982
[TBL] [Abstract][Full Text] [Related]
50. Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.
Confavreux C; Chapuis-Cellier C; Arnaud P; Robert O; Aimard G; Devic M
J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1308-12. PubMed ID: 3794738
[TBL] [Abstract][Full Text] [Related]
51. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
52. Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I.
Verjans E; Theys P; Delmotte P; Carton H
J Neurol; 1983; 229(3):155-65. PubMed ID: 6191007
[TBL] [Abstract][Full Text] [Related]
53. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
[TBL] [Abstract][Full Text] [Related]
54. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
Dachsel R; Köppel C
Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
[TBL] [Abstract][Full Text] [Related]
55. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
Bednárová J; Stourac P; Adam P
Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
[TBL] [Abstract][Full Text] [Related]
56. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients.
Ersoy E; Kuş CN; Sener U; Coker I; Zorlu Y
Eur J Neurol; 2005 Mar; 12(3):208-11. PubMed ID: 15693810
[TBL] [Abstract][Full Text] [Related]
57. Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.
Baumhefner RW; Tourtellotte WW; Syndulko K; Staugaitis A; Shapshak P
Ital J Neurol Sci; 1989 Feb; 10(1):19-32. PubMed ID: 2925343
[TBL] [Abstract][Full Text] [Related]
58. Azathioprine and methotrexate in multiple sclerosis.
Fernández O; Fernández V; De Ramón E
J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
[TBL] [Abstract][Full Text] [Related]
59. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Patrick BA; Sobczyk W; Wisniewski HM
J Neurol Sci; 1992 May; 109(1):64-8. PubMed ID: 1381411
[TBL] [Abstract][Full Text] [Related]
60. Rituximab in a patient with multiple sclerosis--effect on B cells, plasma cells and intrathecal IgG synthesis.
Petereit HF; Moeller-Hartmann W; Reske D; Rubbert A
Acta Neurol Scand; 2008 Jun; 117(6):399-403. PubMed ID: 18031564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
